Clinical trial
Radiation Therapy With or Without Goserelin in Treating Patients Who Have…
NCT00423475 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00423475 |
|---|---|
| Title | Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer |
| Official title | Phase III Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Goserelin in Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer |
| Lead sponsor | UNICANCER, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | goserelin acetate, adjuvant therapy, radiation therapy |
| Enrollment | 743 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2015 |
| First posted | Jan 18, 2007 |
| Last update posted | May 17, 2018 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: